All lobbying filings

Bluebird Strategies

Bluebird Strategies filed a Q3 report for Facioscapulohumeral Muscular Dystrophy (FSHD) Society on October 16, 2026.

Lobbying for Facioscapulohumeral Muscular Dystrophy (FSHD) Society · Research-focused patient support organization

As filed: BLUEBIRD STRATEGIES for FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY (FSHD) SOCIETY.

All filings by Bluebird Strategies · Everything Facioscapulohumeral Muscular Dystrophy (FSHD) Society has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 16, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

Massachusetts

Official filing document

Government bodies contacted 1

SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Budget/Appropriations

Funding eligibility for FSHD research as part of the FY26 Senate Defense Peer Reviewed Medical Research Program

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.